Schattenberg, Joern M.; Straub, Beate K.
On the value and limitations of liver histology in assessing non-alcoholic steatohepatitisJOURNAL OF HEPATOLOGY. Bd. 73. H. 6. 2020 S. 1592-1593
Triantafyllias, K.; Heller, C.; De Blasi, M. et al.
OPTICAL SPECTRAL TRANSMISSION TO ASSESS THERAPY RESPONSE IN PATIENTS WITH ARTHRITIS: A COMPARATIVE STUDY WITH CLINICAL, LABORATORY AND ULTRASONOGRAPHIC ACTIVITY MARKERS.ANNALS OF THE RHEUMATIC DISEASES. Bd. 79. 2020 S. 1240-1240
Labenz, Christian; Toenges, Gerrit; Schattenberg, Joern M. et al.
Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing StrategiesCLINICAL AND TRANSLATIONAL GASTROENTEROLOGY. Bd. 11. 2020
Levy, Antonin; Wagner, Anna D.; Chargari, Cyrus et al.
Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary positionEUROPEAN JOURNAL OF CANCER. Bd. 135. 2020 S. 103-112
Galle, Peter R.; Finn, Richard S.; Qin, Shukui et al.
Patient-reported outcomes (PROs) from the Phase III IMbrave150 trial of atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) as first-line treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Reig, Maria; Galle, Peter R.; Kudo, Masatoshi et al.
Pattern of progression in advanced HCC treated with ramucirumab/placebo: Results from two randomized phase III trials (REACH/REACH-2)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Reig, Maria; Galle, Peter R.; Kudo, Masatoshi et al.
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumabLIVER INTERNATIONAL. 2020
Schattenberg, Joern M.; Labenz, Christian; Woerns, Marcus-Alexander et al.
Patterns of liver injury in COVID-19-a German case seriesUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. Bd. 8. H. 7. 2020 S. 814-819
Smyth, Elizabeth C.; Moehler, Markus
Pembrolizumab in First-line Gastric Cancer: Win, Lose, or Draw?JAMA ONCOLOGY. Bd. 6. H. 10. 2020 S. 1539-1541
Parodis, Ioannis; Adamichou, Christina; Aydin, Selda et al.
Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritisRHEUMATOLOGY. Bd. 59. H. 11. 2020 S. 3424-3434